A Retrospective Comparative Performance Analysis of Multifocal Eyecryl Actv IOL and the World's First Progressive Polyfocal Autofocus Pro IOL.

PURPOSE: This is the first study evaluating the visual outcomes of the novel Progressive Polyfocal Autofocus Pro intraocular lens (IOL) (Lifeline Medical Devices Pvt. Ltd. Aurangabad, India) and comparing them with Eyecryl Actv multifocal IOL (model DIYHS600ROH, Biotech Vision Care Pvt. Ltd. Ahmedabad, India) at the first and sixth weeks after implantation in Indian eyes.

PATIENTS AND

METHODS

A retrospective nonrandomized, comparative study was conducted based on hospital records of patients operated for cataract between January 2019 and January 2021 with bilateral implantation of one of the two presbyopia-correcting IOLs. Patients aged between 11 and 78 years, with preoperative astigmatism of 1 diopter or less and no other ocular disorders, were included. Visual acuity for distance, intermediate and near, refractive outcomes, contrast sensitivity, reading speed, depth of focus, patient satisfaction, and presence of optical phenomenon classically faced with conventional presbyopia-correcting IOLs were evaluated at 6 weeks postoperatively.

RESULTS

Of 104 eligible patients, intermediate visual acuity scores, reading speed, contrast sensitivity, depth of focus, and patient satisfaction were better with the Autofocus Pro IOL (all P<0.001). Negative dysphotopsias were absent in the Autofocus Pro group, whereas they were seen in about one-third of patients in the Multifocal group (P<0.001). Halos and glare were also significantly lower in the Autofocus Pro group. There was no difference in the distance and near visual acuity.

CONCLUSION

This study highlights superior clinical outcomes and patient satisfaction associated with Autofocus Pro IOLs compared to Multifocal IOLs, indicating their potential as a preferred choice for cataract surgery.